News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
34,648 Results
Type
Article (3132)
Company Profile (8)
Press Release (31508)
Section
Business (11773)
Career Advice (98)
Deals (1339)
Drug Delivery (5)
Drug Development (3418)
Employer Resources (4)
FDA (572)
Job Trends (789)
News (17049)
Policy (1196)
Tag
Academia (420)
Africa (49)
Alabama (2)
Allergies (2)
Alliances (3957)
Alzheimer's disease (41)
Antibody-drug conjugate (ADC) (3)
Approvals (570)
Arizona (2)
Artificial intelligence (5)
Asia (2715)
Australia (564)
Bankruptcy (17)
Best Places to Work (528)
C2C Services and Suppliers (3855)
California (35)
Canada (22)
Cancer (8)
Career advice (87)
Career pathing (2)
CAR-T (1)
Cell therapy (5)
China (3)
Clinical research (2440)
Collaboration (3)
Colorado (3)
Connecticut (2)
COVID-19 (251)
CRISPR (1)
C-suite (1)
Cystic fibrosis (8)
Diagnostics (469)
Drug discovery (1)
Drug pricing (2)
Earnings (2104)
Employer resources (3)
Europe (4602)
Events (3874)
Executive appointments (2)
FDA (572)
Florida (5)
Funding (1)
Gene editing (1)
Gene therapy (3)
Georgia (2)
GLP-1 (20)
Government (310)
Healthcare (751)
Hotbed/Location (22786)
Illinois (5)
Indiana (3)
Infectious disease (251)
Inflammatory bowel disease (4)
Interviews (11)
IPO (499)
Job creations (261)
Job search strategy (83)
Kansas (7)
Layoffs (21)
Legal (159)
Liver cancer (4)
Manufacturing (4)
Maryland (9)
Massachusetts (25)
Medical device (638)
Medtech (638)
Mergers & acquisitions (825)
Metabolic disorders (2)
Missouri (2)
Neuroscience (43)
New Jersey (4)
New York (6)
NextGen Class of 2024 (331)
Non-profit (367)
North Carolina (7)
Obesity (2)
Opinion (13)
Patient recruitment (1)
Pennsylvania (3)
People (4438)
Phase I (872)
Phase II (1145)
Phase III (751)
Podcasts (3)
Policy (5)
Postmarket research (57)
Preclinical (489)
Rare diseases (8)
Real estate (601)
Recruiting (2)
Regulatory (763)
Reports (4)
Research institute (440)
Resumes & cover letters (11)
South America (60)
Startups (373)
Texas (3)
United States (130)
Vaccines (19)
Washington State (2)
Date
Today (8)
Last 7 days (30)
Last 30 days (103)
Last 365 days (1760)
2024 (958)
2023 (1924)
2022 (2787)
2021 (2958)
2020 (3065)
2019 (2454)
2018 (1950)
2017 (2170)
2016 (1966)
2015 (2328)
2014 (1695)
2013 (1531)
2012 (1217)
2011 (1412)
2010 (1238)
34,648 Results for "biomed realty".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
BioMed Realty Appoints Marie Lewis as Executive Vice President and General Counsel
BioMed Realty, a leading provider of real estate solutions to the life science and technology industries, announced the appointment of Marie Lewis to Executive Vice President and General Counsel.
October 3, 2023
·
2 min read
Drug Development
BioMed X Start Collaboration in Autoimmunity Research with Servier
The new research team at the BioMed X Institute in Heidelberg will develop a novel strategy to selectively target autoreactive plasma cells in autoimmune disease.
June 26, 2024
·
3 min read
Business
Orchestra BioMed Reports First Quarter 2024 Financial Results and Provides a Business Update
Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today reported its first quarter 2024 financial results and provided a business update.
May 13, 2024
·
13 min read
Business
BioMed X Launches New US Institute in New Haven, CT
Connecticut Governor Ned Lamont, New Haven Mayor Justin Elicker, and Josh Geballe, Managing Director of Yale Ventures, participated in the launch ceremony of the new BioMed X Institute on Tuesday, June 11, 2024.
June 13, 2024
·
3 min read
Pharm Country
Psyence Biomed to Participate in the A.G.P. Virtual Healthcare Company Showcase
Psyence Biomedical Ltd (Nasdaq:PBM) (“Psyence Biomed” or the “Company”) today announced that management will host 1x1 meetings with investors during the A.G.P. Virtual Healthcare Company Showcase, which is being held May 21, 2024.
May 17, 2024
·
1 min read
Biotech Bay
BioMed X Institute and Boehringer Ingelheim Successfully Complete Schizophrenia Research Project
German independent research institute BioMed X announces the successful completion of its second neuroscience project in partnership with Boehringer Ingelheim in the field of psychiatric disorders.
May 28, 2024
·
3 min read
Job Trends
New Immuno-Oncology Research Project in Partnership With Merck Starts at the BioMed X Institute in Heidelberg
BioMed X, a German biomedical research institute, announces the start of a new research project in partnership with Merck at its site in Heidelberg, Germany.
April 30, 2024
·
2 min read
Pharm Country
Orchestra BioMed to Participate in Jefferies 2024 Global Healthcare Conference
Orchestra BioMed Holdings, Inc. announced that company management will present and be available for one-on-one meetings at the Jefferies Global Healthcare Conference being held in New York, NY, June 4-6, 2024.
May 22, 2024
·
1 min read
Biotech Bay
Mainz Biomed Reports Results of 2024 Annual General Meeting
Mainz Biomed N.V., a molecular genetics diagnostic company specializing in the early detection of cancer, held its annual general meeting on Friday, May 31, 2024 in Amsterdam, The Netherlands.
May 31, 2024
·
5 min read
Genetown
Harbour BioMed Announces Resubmission of Biologics License Application for Batoclimab to NMPA for Treatment of Generalized Myasthenia Gravis
Harbour BioMed (the “Company"; HKEX: 02142) announces that it has resubmitted the Biologics License Application (BLA) of batoclimab (HBM9161) to the National Medical Products Administration (NMPA) of China for the treatment of generalized myasthenia gravis (gMG).
June 26, 2024
·
4 min read
1 of 3,465
Next
